Pro‐angiogenic TIE‐2‐expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma
暂无分享,去创建一个
M. Sugiyama | M. Mizokami | Y. Osawa | Sachiyo Yoshio | T. Kanto | A. Taketomi | Hirotaka Shoji | Yoshihiko Aoki | K. Kimura | Yohei Mano | M. Atsukawa | M. Fukai | H. Doi | N. Itokawa | T. Arai